Knowledge, Support & Connection
for the Psoriasis Community
For patients, caregivers, and families. Sourced from clinical guidelines and peer-reviewed research.
Trusted psoriasis Information for Patients & Families
Explore Our Resources
Understanding Psoriasis
Symptoms, types, diagnosis, and what to expect
Explore Guide
Living with Psoriasis
Triggers, skincare routines, mental health, and daily strategies
Explore Guide
Caregiving & Support
Self-care, planning, and resources for care partners
Explore Guide
Psoriatic Arthritis
Symptoms, diagnosis, treatment, and daily joint management
Learn More
Psoriasis Treatments
Topicals, biologics, phototherapy, and clinical trials
Explore Guide
Research & News
Latest developments in psoriasis treatment and research
Latest Updates
Patient Stories
Real experiences from people living with psoriasis
Read StoriesStay Informed
Get weekly psoriasis treatment updates, skin care strategies, and community stories: no spam, unsubscribe anytime
We respect your privacy. Unsubscribe anytime.
Recent Articles
- Imsidolimab Heads to FDA Review for Generalized Pustular Psoriasis: What to Know
Imsidolimab, a new IL-36 receptor blocker made by Vanda Pharmaceuticals, is under FDA review for the treatment of generalized pustular psoriasis (GPP), with a decision… - Stelara Biosimilars Are Here: What Lower-Cost Alternatives Mean for Your Psoriasis Treatment
The first swappable biosimilars for Stelara (ustekinumab) hit the market in 2025. Major insurers have already changed their drug lists. WEZLANA (Amgen) was the first… - Tremfya Becomes First IL-23 Biologic Approved for Children with Psoriasis
The FDA approved Tremfya (guselkumab) in September 2025 for children aged 6 and older with moderate-to-severe plaque psoriasis. It’s the first IL-23 inhibitor approved for… - Zoryve Foam Approved for Scalp and Body Psoriasis: A Steroid-Free Topical Option
The FDA approved Zoryve (roflumilast) foam 0.3% in May 2025 for plaque psoriasis on the scalp and body in adults and adolescents aged 12 and…